A double-blind, placebo-controlled, randomized clinical trial of oral selegiline hydrochloride for smoking cessation in nicotine-dependent cigarette smokers
- 1 March 2010
- journal article
- research article
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 107 (2-3) , 188-195
- https://doi.org/10.1016/j.drugalcdep.2009.10.009
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- A randomized controlled trial of oral selegiline plus nicotine skin patch compared with placebo plus nicotine skin patch for smoking cessationAddiction, 2003
- The increasing recalcitrance of smokers in clinical trials II: Pharmacotherapy trialsNicotine & Tobacco Research, 2003
- Selegiline potentiates cocaine-induced increases in rodent nucleus accumbens dopamineSynapse, 2003
- A preliminary placebo-controlled trial of selegiline hydrochloride for smoking cessationBiological Psychiatry, 2003
- Measures of abstinence in clinical trials: issues and recommendationsNicotine & Tobacco Research, 2003
- Monoamine Oxidase and Cigarette SmokingNeuroToxicology, 2002
- Lazabemide, a selective, reversible monoamine oxidase B inhibitor, as an aid to smoking cessationAddiction, 2002
- Effects of selegiline (l-deprenyl) during smoking and short-term abstinencePsychopharmacology, 2002
- Smoking Cessation in WomenCNS Drugs, 2001
- The increasing recalcitrance of smokers in clinical trialsNicotine & Tobacco Research, 2000